INO

Inovio Pharmaceuticals, Inc.

A maker of DNA-based vaccines and medicines that teach the body's own cells to fight disease. The company designs synthetic DNA instructions and delivers them with its hand-held CELLECTRA device, whose brief electrical pulses open tiny pores in cells to target cancers and HPV-related conditions. Founded in 1983 as Biotechnologies & Experimental Research, it later operated as Genetronics and took its current name after acquiring the Norwegian gene-delivery firm Inovio in 2005.

CUSIP: 45773H201HealthcareUS2 holders

Ownership Activity Financials Filings

INO

INO

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Results of Operations and Financial Condition